SCHEMBL4489673

SCHEMBL4489673

COc1cc(-c2cnc(N)c3c(-c4ccc5sc(C)nc5c4)csc23)cc(OC)c1OC

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHB4 P54760 6/20 0.68
FYN P06241 10/20 0.56
PRKD3 O94806 2/20 0.56
MAP4K4 O95819 2/20 0.56
ABL1 P00519 2/20 0.56
CSF1R P07333 2/20 0.56
LYN P07948 2/20 0.56
KIT P10721 2/20 0.56
FGFR1 P11362 2/20 0.56
FLT1 P17948 2/20 0.56
FGFR3 P22607 2/20 0.56
FLT4 P35916 2/20 0.56
KDR P35968 2/20 0.56
FLT3 P36888 2/20 0.56
BLK P51451 2/20 0.56
NEK2 P51955 2/20 0.56
LIMK1 P53667 2/20 0.56
BTK Q06187 2/20 0.56
MAP4K2 Q12851 2/20 0.56
STK3 Q13188 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3534379 0.85 KDR (0.63) EPHB4FYNPRKD3MAP4K4ABL1
SCHEMBL3534416 0.85 KDR (0.63) EPHB4FYNPRKD3MAP4K4ABL1
SCHEMBL4475736 0.81 EPHB4 (1.00) EPHB4FYNKDRBTKLCK
SCHEMBL4471359 0.81 EPHB4 (1.00) EPHB4FYNMAP4K4ABL1CSF1R
SCHEMBL4467196 0.80 EPHB4 (1.00) EPHB4FYNKDRBTKAURKB
SCHEMBL4472168 0.78 EPHB4 (0.72) EPHB4FYNPRKD3MAP4K4ABL1
SCHEMBL3529022 0.78 KDR (0.64) FYNPRKD3MAP4K4ABL1CSF1R
SCHEMBL3530331 0.78 KDR (0.59) EPHB4FYNPRKD3MAP4K4ABL1
SCHEMBL4473618 0.78 EPHB4 (1.00) EPHB4FYNKDRTGFBR1
SCHEMBL4469106 0.77 EPHB4 (0.76) EPHB4FYNKDRTGFBR1CHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7592352-B2 Substituted thieno and furo-pyridines SMITHKLINE BEECHAM CORPORATION (US) 2009-09-22 US disclosed
US-7592352-B2 Substituted thieno and furo-pyridines SMITHKLINE BEECHAM CORPORATION (US) 2009-09-22 US disclosed
US-7592352-B2 Substituted thieno and furo-pyridines SMITHKLINE BEECHAM CORPORATION (US) 2009-09-22 US disclosed
US-20080182868-A1 Novel chemical compounds SMITHKLINE BEECHAM CORPORATION 2008-07-31 US disclosed
US-20080182868-A1 Novel chemical compounds SMITHKLINE BEECHAM CORPORATION 2008-07-31 US disclosed
US-20080182868-A1 Novel chemical compounds SMITHKLINE BEECHAM CORPORATION 2008-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080182868-A1 Novel chemical compounds HRAS, VHL, TP53 EPHB4 2484/4885FYN 405/4885PRKD3 116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.